Andere talen Syngene International Limited Bombay S.E.

Aandelen

SYNGENE

INE398R01022

Vertraagde tijd Bombay S.E. Andere beurzen 11:15:12 26-04-2024			Variatie 5 dagen	Verschil t.o.v. 1 jan (%)
700,6 ^INR	+0,24%		-1,78%	-0,08%

25/04	Transcript : Syngene International Limited, Q4 2024 Earnings Call, Apr 25, 2024
24/04	Syngene International Limited rapporteert resultaten voor het vierde kwartaal eindigend op 31 maart 2024	CI

Andere talen

Krijg toegang tot al het nieuws over alle bedrijven: mis nooit meer een winstgevende beleggingskans!

Gratis inschrijven

Syngene International Limited Recommends Final Dividend for the Financial Year 2024	24/04
Syngene International Limited Reports Earnings Results for the Fourth Quarter Ended March 31, 2024	24/04
Syngene International Limited Reports Earnings Results for the Full Year Ended March 31, 2024	24/04
INDIA STOCKS-Financials drag Indian shares, hit by fading US rate cut hopes	12/04
Syngene Biologics Manufacturing Facility to Be Operational for U.S. and European Customers from Mid-Year	14/03
Bristol Myers CEO says India to have largest R&D presence outside US by 2025	27/02
Syngene International Posts Gains in Fiscal Q3 Consolidated Net Profit	26/01
Syngene International Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023	25/01
Syngene International Limited Appoints Mr. Sibaji Biswas as Additional Director Designated as Executive Director, Effective on April 01, 2024	25/01
Syngene International Completes Acquisition of Stelis Biopharma's Biologics Plant	04/12
Syngene International Limited completed the acquisition of Unit 3 biologics manufacturing facility in Bangalore from Stelis Biopharma Private Limited for INR 6.2 billion.	01/12
FOCUS -Indian drug manufacturers benefit from Big Pharma interest beyond China	27/11
Syngene International COO Steps Down	31-10-23
Syngene International Limited Announces Resignation of Mahesh Bhalgat as Chief Operating Officer, Effective January 31, 2024	31-10-23
Syngene International Limited Announces Resignation of Carl Decicco as Non-Executive Director	25-10-23
Syngene International's Consolidated Profit Jumps in Fiscal Q2; Shares Slump 7%	18-10-23
Syngene International Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023	17-10-23
Syngene International Limited Announces Retirement of Joydeep Kant as Sr. Vice President - Development Services, Effective October 31, 2023	08-10-23
Syngene International Limited(NSEI:SYNGENE) added to FTSE All-World Index	18-09-23
Syngene International Limited Approves A Final Dividend for the Financial Year Ended March 31, 2023	27-07-23

Geen resultaten voor deze zoekopdracht

Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Andere talen Syngene International Limited Bombay S.E.

Aandelen

SYNGENE

INE398R01022

Andere talen

Filters